Drospirenone-Containing Oral Contraceptives and Risk of Adverse Outcomes After Myocardial Infarction

Acute Myocardial Infarction due to Oral Contraceptive

(2014) G. Kocabay et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Pre-infarction angina predicts thrombus burden in patients admitted for ST-segment elevation myocardial infarction

(2012) Tarek A.N. Ahmed et al.   EuroIntervention

Risk of Venous Thromboembolism with Drospirenone in Combined Oral Contraceptive Products

(2010) Naida Sehovic et al.   ANNALS OF PHARMACOTHERAPY

Risk Factors for Heart Attack, Stroke, and Venous Thrombosis Associated With Hormonal Contraceptive Use

(2010) Marina Y. Zakharova et al.   CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS

Effects of Third-Generation Oral Contraceptives on High-Sensitivity C-reactive Protein and Homocysteine in Young Women

(2010) Sabina Cauci et al.   OBSTETRICS AND GYNECOLOGY

Angiographic Quantification of Thrombus in ST-Elevation Acute Myocardial Infarction Presenting with an Occluded Infarct-Related Artery and Its Relationship with Results of Percutaneous Intervention

(2009) FAUSTINO MIRANDA-GUARDIOLA et al.   JOURNAL OF INTERVENTIONAL CARDIOLOGY

Contraceptive Hormone Use and Cardiovascular Disease

(2009) Chrisandra L. Shufelt et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Cardiac death and reinfarction after 1 year in the Thrombus Aspiration during Percutaneous coronary intervention in Acute myocardial infarction Study (TAPAS): a 1-year follow-up study

(2008) Pieter J Vlaar et al.   LANCET